Chapter 1 Report Scope & Research Methodology
1.1 Market Segmentation
1.1.1 Segment Definition
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
1.3.1 Information Procurement
1.3.2 Purchased Database 16
1.3.3 Internal Database
1.3.4 Secondary Sources
1.3.5 Primary Research
1.3.6 Details Of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Three Pillars of Market Estimation
1.6.2 Market Modeling & Forecasting
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Research Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
1.9.3 Objective - 3
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Procedure Type and Technology Type Snapshot
2.3 Clinical Setting Snapshot
2.4 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraint Analysis
3.1.3 Market Opportunity Analysis
3.1.4 Market Challenge Analysis
3.2 Fertility Diagnostic Products: Regulatory Framework and Reimbursement Scenario
3.3 Technology Landscape
3.3.1 Case study published by the National Library of Medicine in March 2024: accuracy of Hystero-Salpingo-Foam Sonography (Hyfosy) for tubal patency testing
3.4 Industry Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestle Analysis
Chapter 4 U.S. Infertility Market Analysis
4.1 U.S. Infertility Market, 2021-2033 (USD Billion)
4.2 Prevalence/Incidence of Infertility in the U.S., by Gender, 2025
4.3 Impact of Infertility Prevalence/Incidence on Demand for Fertility Diagnostics
4.3.1 Case study published by National Library of Medicine: impact of infertility prevalence on demand for fertility diagnostics
4.3.2 Case study published by Raveco Medical in September 2025: importance of early infertility evaluation and its impact on fertility diagnostics demand
Chapter 5 U.S. Fertility Diagnostic Market: TAM, SAM, and SOM Analysis
5.1 Total Addressable Market (TAM) Analysis, 2021 to 2033 (USD Billion)
5.2 Serviceable Addressable Market (SAM) Analysis, 2021 to 2033 (USD Billion)
5.3 Serviceable Obtainable Market (SOM) Analysis, 2021 to 2033 (USD Billion)
Chapter 6 U.S. Fertility Diagnostic Market: Procedure Type Estimates & Trend Analysis
6.1 U.S. Fertility Diagnostic Market: Procedure Type Segment Dashboard
6.2 Procedure Type Movement & Market Share Analysis, 2025 & 2033
6.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, by Procedure Type, 2021-2033 (USD Million)
6.3.1 X-Ray-Based Tubal Patency Testing
6.3.2 Ultrasound-Based Tubal Patency Testing
6.3.3 Proprietary Controlled Contrast Systems
6.3.4 Structural & Morphologic Imaging
6.3.5 Others
Chapter 7 U.S. Fertility Diagnostic Market: Technology Type Estimates & Trend Analysis
7.1 U.S. Fertility Diagnostic Market: Technology Type Segment Dashboard
7.2 Technology Type Movement & Market Share Analysis, 2025 & 2033
7.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, by Technology Type, 2021-2033 (USD Million)
7.3.1 X-Ray-Based Technologies
7.3.2 Ultrasound-Based Technologies
7.3.3 Proprietary Diagnostic Devices
Chapter 8 U.S. Fertility Diagnostic Market: Clinical Setting Estimates & Trend Analysis
8.1 U.S. Fertility Diagnostic Market: Clinical Setting Segment Dashboard
8.2 Clinical Setting Movement & Market Share Analysis, 2025 & 2033
8.3 U.S. Fertility Diagnostic Market Estimates & Forecasts, by Clinical Setting, 2021-2033 (USD Million)
8.3.1 Fertility & Reproductive Medicine Clinics
8.3.2 Gynecology / Women’s Health Practices
8.3.3 Radiology & Imaging Centers
8.3.4 Hospital Outpatient Departments
8.3.5 others
Chapter 9. U.S. Fertility Diagnostic Market: Region Estimates & Trend Analysis
9.1 U.S. Fertility diagnostic Market: Region Movement Analysis
9.2. U.S. Fertility Diagnostic Market: Region Segment Dashboard
9.3. Region Movement & Market Share Analysis, 2025 & 2033
9.4. U.S. Fertility Diagnostic Market Estimates & Forecast, by Region
9.5. West
9.5.1. West Market, 2021-2033 (USD Million)
9.6. Southeast
9.6.1. Southeast Market, 2021-2033 (USD Million)
9.7. Southwest
9.7.1. Southwest Market, 2021-2033 (USD Million)
9.8. Midwest
9.8.1. Midwest Market, 2021-2033 (USD Million)
9.9. Northeast
9.9.1. Northeast Market, 2021-2033 (USD Million)
Chapter 10 U.S. Fertility Diagnostic Market Competitive Landscape
10.1 Participants’ Overview
10.2 Financial Performance
10.3 Product Benchmarking
10.3.1 Gedeon Richter
10.3.2 Femvue (Femasys Inc.)
10.3.3 Thomas Medical (MedGyn)
10.3.4 Koninklijke Philips N.V.
10.3.5 Ge Healthcare
10.3.6 Samsung Healthcare
10.3.7 Cooper Surgical, Inc.
10.3.8 Mindray Ds Usa, Inc.
10.3.9 Vio Healthtech Inc
10.3.10 Fujifilm Sonosite, Inc.
10.3.11 Olympus
10.3.12 Canon Medical Systems
10.3.13 Stryker
10.4 Participant Categorization
10.5 Company Market Position Analysis, 2025
10.6 Company Market Share Analysis, by Procedure Type, 2025
10.7 Strategy Mapping
10.7.1 New Product Launch
10.7.2 Mergers & Acquisitions
10.7.3 Partnership & Collaboration
10.7.4 Market Expansion
10.7.5 Product Approvals
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Percentage of first births, by age of mother: U.S., 2018-2023
Table 4 Annual incidence rates of female infertility diagnoses by age group, active component service women, US armed forces, 2019-2023
Table 5 Common tests for evaluating ovarian reserve and associated costs:
Table 6 Cost comparison - HyFoSy vs HSG
Table 7 Notable fertility diagnostic products available in or relevant to the US market
Table 8 U.S. infertility market, 2021-2033 (USD Billion) Total addressable market (TAM) analysis, 2021 to 2033 (USD Billion)
Table 9 Serviceable addressable market (SAM) analysis, 2021 to 2033 (USD Billion)
Table 10 Serviceable obtainable market (SOM) analysis, 2021 to 2033 (USD Billion)
Table 11 U.S. fertility diagnostic market, by procedure type 2021-2033 (USD Million)
Table 12 U.S. fertility diagnostic market, by technology type, 2021-2033 (USD Million)
Table 13 U.S. fertility diagnostic market, by clinical setting, 2021-2033 (USD Million)
Table 14 U.S. fertility diagnostic market revenue estimates and forecast, by region, 2021-2033 (USD Million)
List of Figures
Figure 1 U.S. fertility diagnostic market segmentation
Figure 2 Market research process
Figure 3 Information procurement
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 U.S. fertility diagnostic market snapshot
Figure 9 U.S. fertility diagnostic market: Procedure type, and technology type snapshot
Figure 10 U.S. fertility diagnostic market: Clinical setting snapshot
Figure 11 Competitive landscape snapshot
Figure 12 U.S. fertility diagnostic market dynamics
Figure 13 Market driver relevance analysis (Current & future impact)
Figure 14 Market restraint relevance analysis (Current & future impact)
Figure 15 U.S. fertility diagnostic market: Porter’s five forces analysis
Figure 16 U.S. fertility diagnostic market: PESTLE analysis
Figure 17 Prevalence/incidence of infertility in the US, by gender, 2025 %
Figure 18 U.S. fertility diagnostic market: Procedure Type segment dashboard
Figure 19 U.S. fertility diagnostic market: Procedure Type market share analysis, 2025 & 2033
Figure 20 X-ray-based tubal patency testing market, 2021-2033 (USD Million)
Figure 21 X-ray-based tubal patency testing market, 2021-2033 (Annual procedure type estimates in thousands)
Figure 22 Ultrasound-based tubal patency testing market, 2021-2033 (USD Million)
Figure 23 Ultrasound-based tubal patency testing market, 2021-2033 (Annual procedure type estimates in thousands)
Figure 24 HyCoSy (hysterosalpingo-contrast sonography) market, 2021-2033 (USD Million)
Figure 25 HyCoSy (hysterosalpingo-contrast sonography) market, 2021-2033 (Annual procedure type estimates in thousands)
Figure 26 HyFoSy (hysterosalpingo-foam sonography) market, 2021-2033 (USD Million)
Figure 27 HyFoSy (hysterosalpingo-foam sonography) market, 2021-2033 (Annual procedure type estimates in thousands)
Figure 28 Other markets, 2021-2033 (USD Million)
Figure 29 Other markets, 2021-2033 (Annual procedure type estimates in thousands)
Figure 30 Proprietary controlled contrast systems market, 2021-2033 (USD Million)
Figure 31 Proprietary controlled contrast systems market, 2021-2033 (Annual procedure type estimates in thousands)
Figure 32 Structural & morphologic imaging market, 2021-2033 (USD Million)
Figure 33 Structural & morphologic imaging market, 2021-2033 (Annual procedure type estimates in thousand)
Figure 34 Others market, 2021-2033 (USD Million)
Figure 35 Others market, 2021-2033 (Annual procedure type estimates in thousands)
Figure 36 U.S. fertility diagnostic market: Technology type segment dashboard
Figure 37 U.S. fertility diagnostic market: Technology type market share analysis, 2025 & 2033
Figure 38 X-ray-based technologies market, 2021-2033 (USD Million)
Figure 39 Ultrasound-based technologies market, 2021-2033 (USD Million)
Figure 40 Proprietary diagnostic devices market, 2021-2033 (USD Million)
Figure 41 U.S. fertility diagnostic market: Clinical setting segment dashboard
Figure 42 U.S. fertility diagnostic market: Clinical setting market share analysis, 2025 & 2033
Figure 43 Fertility & reproductive medicine clinics market, 2021-2033 (USD Million)
Figure 44 Gynecology / women’s health practices market, 2021-2033 (USD Million)
Figure 45 Radiology & imaging centers market, 2021-2033 (USD Million)
Figure 46 Hospital outpatient departments market, 2021-2033 (USD Million)
Figure 47 Others market, 2021-2033 (USD Million)
Figure 48 USfertility diagnostic market: Region movement analysis
Figure 49 U.S. fertility diagnostic market: Region segment dashboard
Figure 50 Northeast market, 2021-2033 (USD Million)
Figure 51 Southeast market, 2021-2033 (USD Million)
Figure 52 Southwest market, 2021-2033 (USD Million)
Figure 53 Midwest market, 2021-2033 (USD Million)
Figure 54 West market, 2021-2033 (USD Million)
Figure 55 Company categorization
Figure 56 Company market position analysis, 2025
Figure 57 Strategy mapping
